Ocular Emergencies, Orbital Infections, ROP, and Systemic Manifestations

Ocular Emergencies, Orbital Infections, ROP, and Systemic Manifestations

Paediatric ophthalmic emergencies encompass acute infections, neonatal exposures, sight-threatening vascular proliferations in preterm infants, and penetrating trauma. Because infants and young children have limited verbal capacity and rapid disease progression, the paediatrician must master rapid bedside differentiation of benign periocular complaints from acute vision- and life-threatening orbital emergencies.

---

Preseptal vs Postseptal (Orbital) Cellulitis

The orbital septum is a thin, fibrous sheet of connective tissue that originates from the orbital periosteum (arcus marginale) and inserts into the tarsal plates of the upper and lower eyelids. It serves as a formidable anatomical barrier separating the superficial lid structures from the deep intraorbital compartment. Infections are strictly categorized by their anatomical relationship to this septum.

               [Anatomy of the Orbital Compartment]
                                |
       +------------------------+------------------------+
       |                                                 |
[Anterior to Septum]                             [Posterior to Septum]
  - PRESEPTAL CELLULITIS                           - POSTSEPTAL (ORBITAL) CELLULITIS
  - Superficial facial skin infection              - Deep intraorbital infection
  - Source: Insect bite, skin cut, dacryocystitis   - Source: Ethmoid sinusitis (Lamina papyracea)
  - Normal vision, NO proptosis                    - PROPTOSIS, PAINFUL OPHTHALMOPLEGIA
  - Painless, full extraocular motility            - DECREASED VISUAL ACUITY, + RAPD
  - Pupils reactive, no RAPD                       - Emergency contrast CT; IV broad antibiotics

Pathophysiology and Microbiology

• Preseptal (Periorbital) Cellulitis: Involves only the subcutaneous tissues anterior to the orbital septum. It typically arises from external cutaneous breaches, such as local insect bites, facial abrasions, hordeolum (stye), or acute dacryocystitis. Causative pathogens include Staphylococcus aureus (including community-acquired MRSA), Streptococcus pyogenes (Group A Streptococcus), and Streptococcus pneumoniae.
• Postseptal (Orbital) Cellulitis: Involves deep intraorbital soft tissues posterior to the orbital septum, including orbital fat, extraocular muscles, and neurovascular bundles. In over 85% to 90% of cases, orbital cellulitis develops from direct contiguous spread of acute bacterial paranasal sinusitis. The ethmoid sinus is the primary culprit because its paper-thin lateral bony wall—the lamina papyracea—is riddled with natural neurovascular perforations (anterior and posterior ethmoidal foramina) and congenital bony dehiscences, allowing facile bacterial transmigration. Valveless ophthalmic veins also permit retrograde septic thrombophlebitis. Pathogens encompass polymicrobial flora: S. aureus, S. pneumoniae, S. pyogenes, Haemophilus influenzae, and oral anaerobes (Peptostreptococcus, Bacteroides, Fusobacterium).

Chandler Classification of Orbital Infections

1. Stage I: Preseptal Cellulitis (Inflammatory edema anterior to septum)
2. Stage II: Orbital Cellulitis (Diffuse inflammatory infiltration within orbital adipose tissue without discrete abscess formation)
3. Stage III: Subperiosteal Abscess (SPA) (Pus collection between the periorbita and the bony orbital wall, classically along the medial orbital wall adjacent to the ethmoid sinus)
4. Stage IV: Orbital Abscess (Discrete purulent fluid collection within the intraconal or extraconal orbital soft tissue; severe proptosis and visual loss)
5. Stage V: Cavernous Sinus Thrombosis (Septic thrombophlebitis extending posteriorly into the intracranial cavernous sinus; characterized by bilateral proptosis, rapid chemosis, involvement of cranial nerves III, IV, $V_1, V_2$, and VI, papilloedema, and fluctuating sensorium)

Clinical Differentiation and Red Flags

Diagnostic Workup and Emergency Treatment Protocol

• Neuroimaging: Contrast-enhanced Computed Tomography (CT) of the orbits, paranasal sinuses, and brain is the gold standard imaging modality. It must be ordered immediately whenever any postseptal clinical sign (proptosis, ophthalmoplegia, visual compromise, or inability to examine the globe due to severe lid edema) is identified. Magnetic Resonance Imaging (MRI) with MR venography is superior if intracranial extension or cavernous sinus thrombosis is suspected.
• Medical Therapy: Immediate intravenous broad-spectrum antimicrobial therapy targeting S. aureus, Streptococcus species, and anaerobes: IV Ceftriaxone (or Cefotaxime) PLUS IV Vancomycin (or Flucloxacillin, depending on regional MRSA prevalence) PLUS IV Metronidazole. Adjunctive nasal decongestants and topical saline douches promote sinus drainage.
• Indications for Emergency Surgical Decompression (Endoscopic sinus surgery or open orbital evacuation):
  1. Large, non-medial or mass-effect-producing subperiosteal abscess; small medial collections may be managed with IV antibiotics and close ophthalmology/ENT monitoring if vision is preserved.
  2. Deterioration of visual acuity, loss of red-green color discrimination, or development of an RAPD.
  3. Persistent fever, worsening proptosis, or failure to demonstrate objective clinical improvement after 24 to 48 hours of intravenous broad-spectrum antimicrobials.

---

Ophthalmia Neonatorum

Ophthalmia neonatorum (neonatal conjunctivitis) is defined as any conjunctival inflammation occurring within the first 28 days of life. Infection is most commonly acquired during passage through an infected birth canal. Rapid microbiological identification is paramount because specific pathogens produce rapid corneal destruction and systemic illness.

[<24 Hours Post-Natal: Chemical]
  - Silver nitrate prophylaxis (Credé)
  - Mild injection, watery discharge; self-resolving in 24-48 hours
         |
         v
[Days 2 to 5 Post-Natal: Neisseria gonorrhoeae]
  - HYPERACUTE, COPIOUS PURULENT DISCHARGE ('pus spurting from lids')
  - Severe chemosis, lid edema
  - RISK OF RAPID CORNEAL PERFORATION & BLINDNESS WITHIN 24-48 HOURS!
  - Treatment: Hospitalisation + Systemic IV/IM Ceftriaxone + Frequent saline irrigation
         |
         v
[Days 5 to 14 Post-Natal: Chlamydia trachomatis]
  - Most common bacterial etiology; watery -> mucopurulent discharge
  - Pseudomembranes, palpebral follicular response absent in neonates
  - RISK OF DELAYED CHLAMYDIAL PNEUMONITIS (staccato cough at 4-12 weeks)
  - Treatment: ORAL Azithromycin or Erythromycin (Topical alone is ineffective!)
         |
         v
[Days 6 to 14+ Post-Natal: Herpes Simplex Virus (HSV-2)]
  - Periocular cutaneous vesicles, dendritic epithelial keratitis
  - Risk of fatal disseminated neonatal herpes / encephalitis
  - Treatment: Systemic IV Aciclovir + Topical Ganciclovir/Trifluridine

Etiological Profiles and Management Matrix

1. Chemical Conjunctivitis:
   • Onset: Within <24 hours after birth.
   • Pathology: Transient non-infectious chemical irritation caused by silver nitrate eye drops (Credé's prophylaxis) or rarely erythromycin ointment.
   • Management: Self-limiting; resolves spontaneously within 24 to 48 hours without therapeutic intervention.
2. Neisseria gonorrhoeae:
   • Onset: Classically Days 2 to 5 of life (can occur earlier if membranes ruptured prematurely).
   • Pathology: Gram-negative intracellular diplococci. Characterized by an explosive, hyperacute clinical presentation: intensely tense, swollen violaceous eyelids, massive chemosis, and copious, thick, creamy purulent discharge that re-accumulates immediately upon wiping. N. gonorrhoeae possesses enzymes capable of penetrating intact corneal epithelium, inducing rapid corneal ulceration, stromal melting, anterior chamber perforation, and irreversible panophthalmitis within 24 to 48 hours.
   • Therapy: Emergency hospital admission under contact isolation. Mandatory systemic antimicrobial therapy: single-dose IV or IM Ceftriaxone (25 to 50 mg/kg, maximum 125 mg to 250 mg; or cefotaxime if hyperbilirubinemia precludes ceftriaxone). Frequent topical ocular saline lavages (every 15 to 30 minutes initially) to clear cytolytic purulent enzymes. Treat mother and sexual partner; investigate and co-treat for Chlamydia trachomatis.
3. Chlamydia trachomatis (Serovars D–K):
   • Onset: Classically Days 5 to 14 of life.
   • Pathology: Obligate intracellular bacterium; the most common overall infectious cause of ophthalmia neonatorum in industrialized countries. Presents with mild-to-moderate hyperemia, eyelid edema, and mucopurulent discharge, occasionally accompanied by friable pseudo-membranes. The conjunctival lymphoid layer is immature at birth, so neonates develop a papillary rather than a classic follicular response.
   • Systemic Risk and Mandate for Oral Therapy: Topical antibiotics are strictly inadequate because C. trachomatis colonizes the infant's nasopharyngeal mucosa, middle ear, and respiratory tract. Infected infants can develop delayed chlamydial interstitial pneumonitis between 4 and 12 weeks of age, presenting with a pathognomonic paroxysmal 'staccato' cough, tachypnea, bilateral diffuse interstitial pulmonary infiltrates, and peripheral blood eosinophilia (without fever).
   • Therapy: Mandatory systemic oral therapy with oral Azithromycin (20 mg/kg/day once daily for 3 days) or oral Erythromycin (50 mg/kg/day divided in 4 doses for 14 days). Monitor infants for infantile hypertrophic pyloric stenosis following macrolide therapy. Evaluate and treat the mother and her sex partners.
4. Herpes Simplex Virus (HSV):
   • Onset: Days 6 to 14. Unilateral or bilateral conjunctival injection, serosanguinous discharge, periocular cutaneous vesicles, and microdendritic corneal ulcers stained with fluorescein. Carries high risk of fatal disseminated multiorgan disease or encephalitis. Requires immediate IV Aciclovir (60 mg/kg/day in 3 divided doses) plus topical antiviral drops.

---

Retinopathy of Prematurity (ROP)

Retinopathy of prematurity is a vasoproliferative vitreoretinal disorder affecting the immature retinal vasculature of preterm infants. It represents one of the leading worldwide causes of preventable childhood blindness.

Pathophysiological Cascade: The Two-Phase Model

Normal human retinal vascularization begins at 16 weeks gestation, radiating centrifugally from the optic nerve head toward the periphery. The nasal retinal periphery is fully vascularized by 36 weeks post-menstrual age (PMA), whereas the larger temporal periphery is completed only at full term (40 to 42 weeks PMA).

[Preterm Delivery with Incomplete Retinal Vascularisation]
                         |
                         v
[Phase 1: Hyperoxia & Vaso-Obliteration (Postnatal Weeks 0 to 4)]
  - Exposure to high ambient oxygen (room air / mechanical ventilation)
  - Sudden drop in local hypoxia triggers down-regulation of VEGF and IGF-1
  - Arrest of peripheral vessel growth; vaso-obliteration of existing capillaries
                         |
                         v
[Phase 2: Hypoxia & Neovascular Proliferation (Postnatal Weeks 4 to 10+)]
  - Maturing, non-vascularized peripheral retina becomes severely ischemic and hypoxic
  - Massive pathological overproduction of VEGF and IGF-1
  - Abnormal neovascular endothelial proliferation at vascular-avascular junction
  - Ridge formation, extraretinal fibrovascular proliferation, tractional retinal detachment

Screening Eligibility Criteria

ROP screening criteria vary by country. UK 2024 guidance recommends screening for:

• Infants born at <31+0 weeks gestation; OR
• Infants with birthweight <1501 g. Consider screening infants born at 31+0–31+6 weeks, especially with additional risk factors.
• First screen if born <31+0 weeks: at 31+0–31+6 weeks PMA or 4 completed postnatal weeks (28–34 days), whichever is later.
• First screen if eligible and born >=31+0 weeks: at 36+0–36+6 weeks PMA or 4 completed postnatal weeks (28–34 days), whichever is sooner.

Anatomical Zonation, Staging, and 'Plus Disease'

Retinopathy is categorized using the International Classification of Retinopathy of Prematurity (ICROP):

                     [ICROP Retinal Zones]
  
        +-------------------------------------------+
        |  Zone III: Residual temporal crescent     |
        |   +------------------------------------+  |
        |   | Zone II: Extends to nasal ora      |  |
        |   |   +----------------------------+   |  |
        |   |   | Zone I: Radius = 2x disc-  |   |  |
        |   |   |         fovea distance     |   |  |
        |   |   |         (Posterior Pole)   |   |  |
        |   |   +----------------------------+   |  |
        |   +------------------------------------+  |
        +-------------------------------------------+

• Zones (Location):
  • Zone I: Inner circular zone centered on optic disc, radius equal to twice the distance from disc center to fovea center. (Disease here carries the poorest prognosis).
  • Zone II: Concentric ring extending from Zone I border to the nasal ora serrata.
  • Zone III: Residual crescent of temporal retina outside Zone II.
• Stages (Severity at Vascular-Avascular Boundary):
  • Stage 1 (Demarcation Line): A thin, flat, white line separating vascular from avascular retina.
  • Stage 2 (Ridge): Demarcation line gains height, volume, and width, elevating into a prominent pink-white ridge.
  • Stage 3 (Extraretinal Fibrovascular Proliferation): Neovascular tufts and fibrous tissue erupt from the ridge into the vitreous body.
  • Stage 4 (Partial Retinal Detachment): Subtotal tractional detachment (4A: sparing fovea; 4B: macula detached).
  • Stage 5 (Total Retinal Detachment): Funnel-shaped complete retinal detachment resulting in leukocoria and blindness.
• 'Plus Disease': Marked dilatation and tortuosity of retinal arterioles and veins in the posterior pole (Zone I). Indicates severe, active hemodynamic shunting and aggressively progressing disease. Designated by a '+' symbol (e.g., Zone II, Stage 3+).

Treatment Indications

ETROP Type 1 ROP treatment criteria are listed below. UK guidance recommends treatment as soon as possible within 48 hours for aggressive ROP or Zone I stage 3 plus, and within 48–72 hours for other treatment-requiring disease:

• Zone I, any stage with Plus disease
• Zone I, Stage 3 without Plus disease
• Zone II, Stage 2 or Stage 3 with Plus disease (ETROP). UK guidance treats Zone II stage 2 plus as borderline: treat or re-examine within one week.

Therapeutic Modalities:

1. Peripheral Retinal Laser Photocoagulation: Gold-standard definitive therapy. Transpupillary diode laser ablates the ischemic, avascular peripheral retina, permanently extinguishing the cellular source of pathological VEGF production.
2. Intravitreal Anti-VEGF Injections (Ranibizumab or Bevacizumab): Monoclonal antibodies targeting VEGF injected directly into the mid-vitreous. Particularly advantageous for severe Zone I disease (promotes continued normal physiological vessel growth into periphery without destroying visual fields). Requires prolonged, intensive outpatient surveillance due to late disease recurrence and theoretical systemic endothelial suppression risks.

---

Acute Paediatric Ocular Trauma

Ocular injuries in childhood require systematic evaluation to exclude full-thickness rupture of the globe before performing any manipulative diagnostic procedures.

Corneal Abrasion

• Mechanism: Tangential fingernail scratch, paper cut, or foreign object scraping corneal surface epithelium.
• Presentation: Intense sharp ocular pain, blepharospasm, lacrimation, foreign body sensation, and photophobia.
• Diagnosis: Instillation of sterile topical fluorescein dye followed by examination under a cobalt blue light. Epithelial defects appear as bright, glowing green abrasions against a dark blue background. Evert eyelids to search for retained subtarsal foreign bodies.
• Management: Topical antibiotic ointment or drops (e.g., chloramphenicol, fusidic acid, or polymyxin B) to prevent secondary microbial keratitis; short-acting cycloplegic (cyclopentolate) to alleviate painful ciliary muscle spasm; oral analgesics. The cornea heals rapidly within 24 to 48 hours.

Traumatic Hyphaema

• Pathology: Collection of red blood cells in the anterior chamber following blunt ocular contusion (e.g., ball strike, elastic band snap) that tears iris or ciliary body microvessels.
• Complications: Secondary rebleeding (occurring classically between Days 2 and 5), acute secondary glaucoma from trabecular meshwork erythrocyte clogging, and permanent corneal endothelial blood staining.
• Management: Strict bed rest with head of bed elevated to 30 to 45 degrees (promotes gravitational settling of blood away from the visual axis and pupillary aperture); rigid Fox eye shield; topical cycloplegics (atropine 1%); topical corticosteroids under ophthalmology guidance. Avoid NSAIDs or aspirin. In patients with sickle cell trait/disease, hyphaema is a visual emergency because sickled erythrocytes obstruct trabecular meshwork rapidly; avoid systemic or topical carbonic anhydrase inhibitors (acetazolamide/dorzolamide) as they induce metabolic acidosis and hemoconcentration that worsens anterior chamber sickling.

Open Globe / Penetrating Eye Injury: Emergency Protocol

A full-thickness breach of the cornea, sclera, or limbus by a sharp object or high-velocity projectile represents a catastrophic surgical emergency.

              [Suspicion of Open Globe Injury]
                             |
    +------------------------+------------------------+
    |                                                 |
[CLINICAL RED FLAGS]                          [EMERGENCY PROTOCOL]
  - Peaked, 'teardrop' pupil pointing toward wound      - IMMEDIATELY STOP ALL FURTHER EXAM
  - Extrusion of intraocular contents (uveal tissue)   - DO NOT APPLY PRESSURE OR EYE PATCH!
  - Shallow or flat anterior chamber                    - Place RIGID EYE SHIELD resting on bone
  - Subconjunctival 360-degree chemosis / hemorrhage    - Nil by mouth (NPO) for urgent surgery
  - Visible foreign body / wound                       - IV antiemetics (prevent coughing/vomiting)
                                                       - IV broad-spectrum antibiotics

---

Ophthalmic Signs of Paediatric Systemic Disease

The eye provides an unobstructed window into systemic vascular, metabolic, neurocutaneous, and autoimmune pathophysiology: